Active

Contract Opportunity

Procurement Technical Assistance Centers (PTACs) are an official government contracting resource for small businesses. Find your local PTAC (opens in new window) for free government expertise related to contract opportunities.

Department of Veterans Affairs
Network Contracting Office (NCO) 16
Request For Information (RFI)

DISCLAIMER: THIS IS A SOURCES SOUGHT NOTICE ONLY. THIS SYNOPSIS IS NOT A REQUEST FOR QUOTE, PROPOSAL, OR BID. This notice is not a solicitation as defined by FAR 2.101, therefore it shall not be construed as a commitment by the Government to enter into a contract, nor does it restrict the Government to an acquisition approach. All information contained in this Request for Information (RFI) is preliminary as well as subject to amendment and is in no way binding on the Government. Information submitted in response to this notice is voluntary; the Government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the Government. The Government is requesting that restrictive or proprietary markings not be used in response to this notice. If a solicitation is released, it will be synopsized in the Federal Contract Opportunities website or GSA. It is the responsibility of the interested parties to monitor these sites for additional information pertaining to this RFI.
1. Title: Radiopharmaceuticals and associated materials
2. Purpose: The purpose of this RFI is to identify potential sources which will aid in defining the procurement strategy (e.g., set-aside, sole source, unrestricted) for a solicitation the VA intends on issuing shortly for the following:
Item #
Brief Description of Service*
Unit
Qty
1
I-123 - 100 uCi FOR THYROID UPTAKE ONLY
EA
100
2
I-123 - 200 uCi FOR THYROID IMAGING ONLY
EA
100
3
1-123 - 5 mCi mini cap FOR NUC MED CA METS THYROID IMAGING
EA
15
4
99mTc SULFUR COLLOID - 10 mCi FOR NUC MED MARROW BONE IMAGING
EA
100
5
99mTc FILTERED Sulfur Colloid - 1 mCi FOR LYMPHOSCINITIGRAPHY
EA
25
6
99mTc 04 - 25 mCi FOR NU MED HEMANGIOMA LIVER
EA
75
7
99mTc CHOLETEC (Mebrofenin) - 10 mCi FOR HEPATOBILIARY/GALLBLADDER
EA
40
8
99mTc Sulfur Colloid - 1 mCi FOR GASTRIC EMPTYING
EA
150
9
99mTc MDP - 25 mCi FOR NUC MED BONE SCAN, WHOLE BODY
EA
475
10
TI-201 - 4 mCi FOR NUC MED REST/STRESS MYOCARDIUM (SPECT)
EA
100
11
99mTc MAA - 5 mCi FOR NUC MED LUNG PERFUSION V/Q
EA
40
12
Xe-133 - 25 mCi FOR NUC MED LUNG VENTILATION V/Q
EA
40
13
99mTc Mag 3 - 10 mCi FOR NUC MED RENAL SCAN AND FLOW
EA
35
14
Ga-67 - 6mCi FOR NUC MED TUMOR LOCALIZATION, WHOLE BODY
EA
10
15
In-111 PENTETREOTIDE (OCTREOTIDE) - 6 mCi FOR NUC MED NEUROENDOCRINE TUMOR
EA
3
16
I-123 IOFLUPANE 3-5 mCi FOR DAT SCAN BRAIN IMAGING
EA
15
17
I-123 LOBENGUANE SULFATE (ANDREVIEW) 1-10 FOR MIBG ADRENAL SCAN (ANDREVIEW)
EA
10
18
In-111 OXINE LEULOCYTES - .5 mCi FOR NUC MED WHITE BLOOD CELL LOCALIZATION
EA
12
19
I-131 PHYSICIAN DETERMINED FOR NUC MED THERAPY THYROID
EA
25
20
In-111 DTPA - .5 mCi FOR NUC MED CISTERNOGRAM
EA
4
21
99mTc SESTAMIBI (CARDIOLITE) - 30 mCi FOR MYOCARDIAL PERFUSION SINGLE STUDY HIGH DOSE
EA
1000
22
99m Tc SESTAMIBI (CARDIOLITE) - 10 mCi FOR NUC MED REST/STRESS PERFUSION SINGLE STUDY LOW DOSE
EA
500
23
ADDITIONAL SUPPORT PHARMACEUTICAL, KINEVAC SINCALIDE FOR INJECTION 5 mcg
EA
15
24
ADDITIONAL SUPPORT PHARMACEUTICAL, HESPAN/HERARIN SYRINGE KIT FOR WBC BLOOD TAB
EA
15
25
ADDITIONAL SUPPORT PHARMACEUTICAL, ULTRATAG RBC 5 VIAL KIT
EA
15
26
SUPPORT ITEM, A/C MASK, BACTERIA FILTER, ULTRAFLEX TUBING/BIODEX STOCK NO. 132-681
EA
50
27
SUPPORT ITEM, DRIERITE, 1 LB/BIODEX STOCK NO. 139-101
EA
10
28
SUPPORT ITEM, SODA-LIME, 1 LB/BIODEX STOCK NO. 130-019
EA
10
29
SUPPORT ITEM, DRIERITE DISPOSABLE CARTRIDGE
EA
50
30
SUPPORT ITEM, SODA-LIME DISPOSABLE CARTRIDGE
EA
50
31
SUPPORT ITEM, 2.0mCi 68 GERMANIUM 27CM LARGE VOLUME PHANTOM
EA
1
32
SUPPORT ITEM, CO 57 RECTANGULAR 10mCi COBLALT FLOOD UNIFORMITY
EA
2
33
SUPPORT ITEM, 1.0mCi 68 GERMANIUM LINE SOURCES
EA
2
34
SUPPORT ITEM, 10 mCi 153 GADOLINIUM LINE SOURCE FOR SYMBIA AUTO QC
EA
2
35
SUPPORT ITEM, 50uCi 57 COBALT ENCAPSULATED POINT FOR SYMBIA AUTO QC
EA
2
36
SUPPORT ITEM, 12mCi 57 COBALT LINE SOURCE
EA
1
37
SUPPORT ITEM, PHARMACIST CALLOUT AFTER HOURS
EA
25
38
Fludeoxyglucose F-18 FDG-PET Scan for wide range of oncology
EA
300
39
Fluciclovine F-18 Axumin-PET Scan for Prostate Cancer
EA
75
40
Gallium 68, Ga680 - Dotatate - PET Scan for Neuroendocrine Tumors
EA
40
41
Florbetapir F-18 Amyvid - PET Scan for Alzheimer's detection
EA
20
42
F-18 Sodium Fluoride (NaF) - PET Scan for skeletal Imaging
EA
20
43
Tc99m Ceretec for brain and labeled white cell
EA
5
44
Tc99m PYP
EA
200
45
Tc99m Rotop DMSA
EA
1
46
Pyrophosphate Kit (Vial)
EA
10
47
Potassium Iodide Tablets
EA
50
48
Absorbent Rolls
EA
12
49
Tc99m Ceretec (WBC)
EA
5
50
Tc99m RBC Denatured RBC Labeling
EA
30
51
I-123 2 mCi mini cap
EA
20
52
GA68 PSMA (Illumet TM)
EA
10
53
Delivery Fee for Axumin and Amyvid
EA
100
54
Pylarify
EA
120
55
Tc99m Myoview
EA
30
56
F-18 Cerianna
EA
8
The overall purpose is to provide delivery of radioactive material(s) in the form of radiopharmaceuticals (radio-isotopes) along with ancillary medications and support materials to Southeast Louisiana Veterans Health Care System (SLVHCS) in the Nuclear Medicine Department, Room 2G221, 2400 Canal Street, New Orleans, LA 70119.
B. Background
Products are used as an Imaging agent/pharmaceutical and administered by IV injection or orally by a Nuclear Medicine Technologist prior to the Nuclear Medicine study.
C. Scope
The contractor shall provide radiopharmaceuticals as ordered, in the specific prescribed doses by SLVHCS, New Orleans, LA

The anticipated Small Business Administration (SBA) size standard for the North American Industry Classification System (NAICS) code 325412 is ____________ (employees or dollars).

3. Responses Requested: The following questions must be answered in response to this RFI.
Answers that are not provided shall be considered non-responsive to the RFI:

a. Where are the requested items/equipment manufactured?

Vendor must attach documentation of this information to be viewed by the government to be considered as part of the Market Research and responsiveness to this Sources Sought notice

b. Are the requested items/equipment manufactured by a Small or Large business? Is the potential vendor in compliance with the Non-Manufacturer Rule (NMR)?

Vendor must attach documentation of this to be viewed by the government to be considered as part of the Market Research and responsiveness to this Sources Sought notice

c. Is the Vendor an authorized distributor with access to Original Equipment Manufacturer (OEM) parts which may be required in performance of this requirement?

The VA does not accept grey market items and therefore the Vendor must attach evidence of this access (Authorized Distributor letter) to be viewed by the government to be considered as part of the Market Research and responsiveness to this Sources Sought notice.
d. Name of potential Contractor that possess the capability to fulfill this requirement. Contractors shall also provide the following:

Point(s) of contact name: _______________________________________________
Address: ___________________________________________________
Telephone number: ___________________________________________
Email address: _______________________________________________

Company's business size: ________________________________________________
Data Universal Numbering System (DUNS) #: _______________________________

e. Is your company considered a small business concern, SB, SDVOSB, VOSB, HUBZone, or 8A concern, with the requisite __________________ NAICS code?

Please provide proof of qualifications.

f. Is your company available under any Government Wide Agency Contract (GWAC), General
Services Administration (GSA) Schedule, Indefinite Delivery Indefinite Quantity (IDIQ), and/or
Blanket Purchase Agreement (BPA)?

If so, please identify the contract number for the Government to review as part of this Market Research.

4. Opportunity/Market Pricing: The MEDVAMC is seeking information from potential vendors on their ability to provide the required items/equipment. THIS IS A SOURCES SOUGHT REQUEST FOR INFORMATION (RFI) ONLY. Small Business Concerns are encouraged to provide responses to this RFI in order to assist the MEDVAMC in determining potential levels of competition and general market pricing available in the industry. Therefore, vendors are requested to submit estimated market research pricing along with their responses to the above. The estimated pricing will be considered when determining the procurement strategy for the forthcoming solicitation.

5. Instructions and Response Guidelines: Questions regarding this RFI shall be submitted no later than 13:00 (CST), March 15, 2023 via email to Oney.kelly@va.gov

RFI responses are due by 13:00 (CST), Friday, Monday 20, 2023; size is limited to 8.5 x 11 inches, 12-point font, with 1-inch margins in Microsoft Word format via email to Oney.kelly@va.gov the subject line shall read: MEDVAMC Radiopharmaceuticals and associated materials. NO SOLICITATION EXISTS AT THIS TIME. There is no page limitation on subparagraphs 3(a) - 3(f).

Please provide the information you deem relevant in order to respond to the specific inquiries of the RFI. Information provided will be used solely by MEDVAMC as Market Research and will not be released outside of the MEDVAMC Purchasing and Contract Team.

7. Contact Information:

Oney Kelly
Oney.kelly@va.gov

Your response to this notice is greatly appreciated!

Attachments/Links